61 – 70 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141(
- Contribution to journal › Published meeting abstract
-
Mark
Tobacco increases dystonia risk but may ameliorate symptoms
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.137-138(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
(
- Contribution to journal › Article
-
Mark
CHCHD2 and Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease.
(
- Contribution to journal › Article
-
Mark
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.
(
- Contribution to journal › Article
-
Mark
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
(
- Contribution to journal › Article
-
Mark
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
2015) In Neurology(
- Contribution to journal › Article
-
Mark
The TOS2 study: An international multi-centre audit assessing the standard of neurological examination
(
- Contribution to journal › Published meeting abstract
-
Mark
Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C : an observational cohort study
(
- Contribution to journal › Article